Alternative splicing and variation in N- and O-glycosylation give rise to the various CD44 isoforms distinguishable by their differential roles in breast cancer CD44s, one of the most expressed CD44 isoforms, is up-regulated in primary tumors but correlates with overall patient survival [62,63]. This evidence concerns the gene CD44 and breast carcinoma.